Session

Overview: The standard treatment for locally advanced cervical cancer has changed dramatically over time. This has included the development of a target-volume concept, new applicators, image-guided external beam radiotherapy with volume reduction, concomitant cis-platin-based chemotherapy, and MR image-guided adaptive brachytherapy. These new developments were implemented in the EMBRACE I and II studies, achieving excellent results in terms of both tumour control and a continuous reduction in adverse events over the years. This teaching lecture will integrate the experience from EMBRACE II into clinical practice from clinical and physical perspectives.